is semaglutide being banned getting Critics are debating whether GLP-1 drugs should be in sports for GLP-1 weight-loss drugs are a

One explanation for the differences in the commercial/Medicare ratio may be due to the data collection period taking place soon after launch of semaglutide QW

has served on advisory panels for Bayer and Novo Nordisk, has received research funding from IQVIA, Roche and Sanofi, has received grants from the Chief Scientist Office, Diabetes UK, the European Commission, the Juvenile Diabetes Research Foundation and the Medical Research Council, has served on a speakers bureau for Novo Nordisk and holds stock in Bayer and Roche Pharmaceuticals

Fraiser Kansteiner, In major blow for Lilly, Novo strikes deal giving Wegovy preferred access on CVS Caremark formulary (2025)

Clinical trial data for women: A 2025 analysis of the SURMOUNT trials specifically looked at whether reproductive stage (premenopausal, perimenopausal, postmenopausal) affected weight loss with tirzepatide

Rats and mice given liraglutide, and later other GLP-1 drugs, developed thyroid C-cell hyperplasia and C-cell tumors, including medullary thyroid carcinoma, at higher rates than untreated animals